Docetaxel and cisplatin with granulocyte colony-stimulating factor (G-CSF) versus MVAC with G-CSF in advanced urothelial carcinoma: a multicenter, randomized, phase III study from the Hellenic Cooperative Oncology Group (Q33357994)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Docetaxel and cisplatin with granulocyte colony-stimulating factor (G-CSF) versus MVAC with G-CSF in advanced urothelial carcinoma: a multicenter, randomized, phase III study from the Hellenic Cooperative Oncology Group
scientific article

    Statements

    Docetaxel and cisplatin with granulocyte colony-stimulating factor (G-CSF) versus MVAC with G-CSF in advanced urothelial carcinoma: a multicenter, randomized, phase III study from the Hellenic Cooperative Oncology Group (English)
    G Aravantinos
    C Deliveliotis
    D Bafaloukos
    D Mitropoulos
    D Pectasides
    P Papakostas
    C Kourousis
    C Papadimitriou
    Hellenic Cooperative Oncology Group
    9 December 2003

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit